The DOI matches its Crossref record.
Evaluation of clinical diagnostic criteria for neurofibromatosis 2
Abstract
BACKGROUND: Four sets of clinical diagnostic criteria for neurofibromatosis 2 (NF2) have been developed by groups of expert clinicians, but sensitivity has never been formally assessed. The sets of criteria differ for people without bilateral vestibular schwannomas, which are pathognomonic for NF2. OBJECTIVE: To empirically evaluate the four existing sets of clinical diagnostic criteria for NF2. METHODS: The study was based on 163 of 403 people in the United Kingdom NF2 registry (41%) who presented without bilateral vestibular schwannomas. The authors applied the sets of criteria to each person at initial assessment and at the most recent clinical evaluation (mean +/- SE length of follow-up, 13 +/- 1 years). RESULTS: In people with "definite NF2" and a negative family history of NF2, the 1987 US NIH and 1991 NIH criteria each identify 78% of people at the most recent clinical evaluation but 0% at initial assessment. The National Neurofibromatosis Foundation (NNFF) criteria and the Manchester criteria each identify higher proportions at both time points (NNFF criteria, 91% and 10%; Manchester criteria, 93% and 14%), but the proportions at initial assessment are still low. CONCLUSIONS: None of the existing sets of criteria are adequate at initial assessment for diagnosing people who present without bilateral vestibular schwannomas as having NF2, particularly people with a negative family history of NF2. The authors recommend that a single, revised set of diagnostic criteria be devised to replace all of the existing sets of criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Evans, D. G., Howard, E., Giblin, C., Clancy, T., Spencer, H., Huson, S. M., & Lalloo, F. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33139 · Cited by 988
Self-citationAsthagiri, A. R., Parry, D. M., Butman, J. A., Kim, H. J., Tsilou, E. T., Zhuang, Z., & Lonser, R. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60259-2 · Cited by 665
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective
Ferner, R. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70075-3 · Cited by 511
Evans, D. G. R., Moran, A., King, A., Saeed, S., Gurusinghe, N., & Ramsden, R. (2005) · Otology & Neurotology · doi:10.1097/00129492-200501000-00016 · Cited by 418
Self-citationContact-dependent inhibition of EGFR signaling by Nf2/Merlin
Curto, M., Cole, B. K., Lallemand, D., Liu, C.-H., & McClatchey, A. I. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703010 · Cited by 363
Metadata
- Authors
- Baser, M. E., Friedman, J. M., Wallace, A. J., Ramsden, R. T., Joe, H., & Evans, D. G. R.
- Venue
- Neurology
- Published
- 2002-12-10
- Volume
- 59
- Issue
- 11
- Pages
- 1759-1765
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2059852545
- Cited by
- 222
- References
- 0
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of clinical diagnostic criteria for neurofibromatosis 2. https://app.cochat.ai/papers/10.1212/01.wnl.0000035638.74084.f4
- The paper
- Baser, M. E., Friedman, J. M., Wallace, A. J., Ramsden, R. T., Joe, H., & Evans, D. G. R. (2002). Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology. https://doi.org/10.1212/01.wnl.0000035638.74084.f4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.